{"gene":"NDUFV1","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":1993,"finding":"NDUFV1 encodes the 51-kDa flavoprotein subunit of mitochondrial NADH:ubiquinone oxidoreductase (Complex I), playing an important role in formation of the NADH-binding site and serving as the principal site of electron entry from NADH into the respiratory chain. The gene was chromosomally localized to 11q13.","method":"PCR-based chromosomal localization (fluorescence in situ hybridization and somatic cell hybrid analysis); sequence analysis revealing NADH, FMN, and iron-sulfur binding site motifs","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 — foundational biochemical characterization of the subunit's role replicated across species; consensus across multiple studies","pmids":["8288251"],"is_preprint":false},{"year":1998,"finding":"The NDUFV1 gene contains consensus motifs for NADH, FMN, and iron-sulfur binding within its coding sequence. Its 10-exon genomic structure was characterized, with a CpG island at the transcriptional start site (consistent with housekeeping function) and an NRF-2 binding site in the 5' flanking region. An unexpected 48-bp antisense homology between the NDUFV1 3'UTR and the 5'UTR of gamma-interferon inducible protein (IP-30) was identified.","method":"Genomic cloning, cDNA sequencing, Northern blotting, sequence motif analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — structural/sequence characterization with functional inference, single study","pmids":["9571201"],"is_preprint":false},{"year":2007,"finding":"Transcription factor Sp1 directly activates NDUFV1 transcription; inhibition of Sp1/DNA binding by mithramycin reduced NDUFV1 mRNA levels in neuroblastoma cells, demonstrating Sp1 as a transcriptional regulator of NDUFV1.","method":"Pharmacological inhibition of Sp1 with mithramycin, promoter-binding assays, mRNA quantification in neuroblastoma cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — functional inhibitor assay in cells showing transcriptional control, single study","pmids":["17786189"],"is_preprint":false},{"year":2015,"finding":"NDUFV1 binds the flavin (FMN) cofactor that oxidizes NADH and is the site of Complex I-mediated reactive oxygen species (ROS) production. Sixteen pathogenic missense mutations were functionally characterized: some caused loss of complex I expression, two resulted in assembled but flavin-free complex I, and four produced functionally compromised enzymes; three variants yielded wild-type-equivalent function, challenging their pathogenic assignment.","method":"Yarrowia lipolytica yeast model system; complex I assembly assays, flavin content measurement, NADH oxidation activity assays, mutagenesis of all 16 variants","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — reconstituted yeast model with enzymatic assays and mutagenesis of multiple variants, strong mechanistic resolution","pmids":["26345448"],"is_preprint":false},{"year":2011,"finding":"Arg386 in NDUFV1 is critical for coordinating iron-sulfur clusters; the p.Arg386His mutation affects a conserved residue contiguous to a cysteine that coordinates an Fe ion in the 4Fe-4S domain, validating the molecular model of iron-sulfur cluster coordination by NDUFV1.","method":"Homozygosity mapping, Sanger sequencing, protein conservation analysis, structural modeling","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 3 — genetic and structural modeling evidence; functional inference supported by structural proximity to iron-sulfur coordinating cysteine","pmids":["21696386"],"is_preprint":false},{"year":2022,"finding":"CYTL1 protein competitively binds the N-terminal sequence of NDUFV1 to block MDM2-mediated proteasomal degradation of NDUFV1, thereby stabilizing NDUFV1 protein levels. Stabilized NDUFV1 in turn interacts with Src kinase to attenuate LDHA phosphorylation at tyrosine 10, reducing lactate production and inhibiting glycolytic reprogramming in breast cancer cells.","method":"Co-immunoprecipitation, pulldown assays, proteasome inhibitor experiments, NDUFV1 overexpression/knockdown, metabolic assays (glucose uptake, lactate production), in vitro and in vivo tumor models","journal":"Signal transduction and targeted therapy","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP for protein-protein interactions, functional rescue experiments, and defined metabolic phenotype with multiple orthogonal methods in a single study","pmids":["35115484"],"is_preprint":false},{"year":2022,"finding":"Pathogenic mutations in NDUFV1 mapped to subunit interfaces disrupt Complex I assembly; compound heterozygous variants in NDUFV1 (modeled in the homologous E. coli nuoF subunit) showed reduced NADH oxidase activity and impaired complex assembly as measured by co-immunoprecipitation and time-delayed expression assays.","method":"E. coli model system mutagenesis, membrane vesicle NADH oxidase activity assays, co-immunoprecipitation assembly assays, time-delayed expression assays","journal":"Mitochondrion","confidence":"Medium","confidence_rationale":"Tier 1/2 — bacterial reconstitution with functional assays and assembly assays, single study but multiple orthogonal methods","pmids":["36462614"],"is_preprint":false},{"year":2023,"finding":"NDUFV1 overexpression in renal tubular cells improves mitochondrial integrity and Complex I activity, reduces oxidative stress and apoptosis following ischemia-reperfusion injury; NDUFV1 knockdown aggravated H2O2-induced cell injury, establishing NDUFV1 as required for maintaining mitochondrial homeostasis and Complex I function.","method":"In vivo mouse renal I/R model with NDUFV1 overexpression, siRNA knockdown in TCMK-1 cells, Complex I activity assays, mitochondrial morphology assessment, oxidative stress and apoptosis assays","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — loss- and gain-of-function in both in vivo and in vitro models with defined cellular phenotypes, single study","pmids":["37029501"],"is_preprint":false},{"year":2020,"finding":"Biallelic loss-of-function mutations in NDUFV1 cause loss of NDUFV1 protein, defective Complex I assembly, and reduced Complex I enzyme activity; complementation with wild-type NDUFV1 restored NDUFV1 protein level, Complex I assembly, and enzyme activity, directly demonstrating the requirement of NDUFV1 for Complex I assembly and function.","method":"Patient-derived cell lines, Western blot for NDUFV1 protein, blue-native PAGE for Complex I assembly, spectrophotometric Complex I enzyme assay, complementation assay with NDUFV1 re-expression","journal":"Genes","confidence":"High","confidence_rationale":"Tier 1/2 — complementation rescue with multiple orthogonal readouts (protein, assembly, enzymatic activity) in patient-derived cells","pmids":["33182419"],"is_preprint":false}],"current_model":"NDUFV1 is the 51-kDa flavin (FMN)-binding core subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase) that constitutes the primary NADH oxidation site and the main entry point for electrons into the respiratory chain, harbors iron-sulfur cluster coordination residues (including a critical Arg386 adjacent to a 4Fe-4S coordinating cysteine), and is the site of Complex I-mediated ROS production; its protein stability is regulated by CYTL1-mediated protection from MDM2-dependent proteasomal degradation, and once stabilized, NDUFV1 interacts with Src to suppress LDHA-Y10 phosphorylation and limit glycolysis, while pathogenic mutations disrupt FMN binding or Complex I assembly, leading to mitochondrial respiratory chain deficiency and diseases including Leigh syndrome and leukoencephalopathy."},"narrative":{"teleology":[{"year":1993,"claim":"Identification of NDUFV1 as the gene encoding the 51-kDa flavoprotein of Complex I established the molecular identity of the principal NADH oxidation site and electron entry point of the mitochondrial respiratory chain.","evidence":"PCR-based chromosomal localization, FISH, and sequence motif analysis revealing NADH, FMN, and Fe-S binding sites","pmids":["8288251"],"confidence":"High","gaps":["No direct enzymatic reconstitution performed at this stage","Functional consequence of individual binding motifs not tested by mutagenesis"]},{"year":1998,"claim":"Characterization of the 10-exon genomic structure, CpG island promoter, and NRF-2 binding site established NDUFV1 as a housekeeping gene under transcriptional control relevant to mitochondrial biogenesis.","evidence":"Genomic cloning, cDNA sequencing, Northern blotting, and promoter motif analysis","pmids":["9571201"],"confidence":"Medium","gaps":["NRF-2-dependent transcriptional regulation not tested functionally","Biological significance of the antisense homology to IP-30 3′UTR unknown"]},{"year":2007,"claim":"Demonstration that Sp1 directly activates NDUFV1 transcription identified a specific transcription factor pathway controlling expression of this core respiratory chain subunit.","evidence":"Mithramycin-mediated Sp1 inhibition with mRNA quantification in neuroblastoma cells","pmids":["17786189"],"confidence":"Medium","gaps":["Direct Sp1 binding to the NDUFV1 promoter not confirmed by ChIP","Relative contributions of Sp1 versus NRF-2 to physiological NDUFV1 expression unresolved"]},{"year":2011,"claim":"The p.Arg386His mutation established that Arg386 is critical for iron–sulfur cluster coordination in the 4Fe-4S domain of NDUFV1, linking structural integrity of the Fe-S center to disease pathogenesis.","evidence":"Homozygosity mapping, Sanger sequencing, conservation analysis, and structural modeling in patients with Complex I deficiency","pmids":["21696386"],"confidence":"Medium","gaps":["No direct biochemical measurement of Fe-S cluster content or redox activity for this mutant","Functional impact inferred from structural proximity rather than reconstituted enzyme assays"]},{"year":2015,"claim":"Systematic mutagenesis of 16 pathogenic NDUFV1 variants resolved how individual mutations cause disease—either by preventing FMN incorporation, abolishing Complex I assembly, or producing catalytically impaired enzyme—and reclassified three variants as non-pathogenic.","evidence":"Yarrowia lipolytica reconstitution with assembly assays, flavin content measurement, and NADH oxidation activity for each variant","pmids":["26345448"],"confidence":"High","gaps":["ROS production rates of individual mutant enzymes not quantified","Findings in yeast model await confirmation in mammalian Complex I context"]},{"year":2020,"claim":"Complementation rescue in patient-derived cells provided direct proof that NDUFV1 is required for Complex I assembly and enzymatic activity, closing the gap between genetic association and biochemical causality.","evidence":"Patient-derived cell lines with biallelic mutations; Western blot, BN-PAGE, spectrophotometric Complex I assay, and rescue by wild-type NDUFV1 re-expression","pmids":["33182419"],"confidence":"High","gaps":["Tissue-specific consequences (e.g., in neurons) not modeled","Supercomplex formation status in rescued cells not assessed"]},{"year":2022,"claim":"Discovery that CYTL1 stabilizes NDUFV1 by blocking MDM2-mediated proteasomal degradation, and that stabilized NDUFV1 interacts with Src to suppress LDHA-Y10 phosphorylation, revealed an unexpected non-respiratory function of NDUFV1 in restraining glycolytic reprogramming.","evidence":"Reciprocal Co-IP, proteasome inhibitor experiments, metabolic assays, and in vivo tumor models in breast cancer cells","pmids":["35115484"],"confidence":"High","gaps":["Whether the NDUFV1-Src interaction occurs in non-cancer tissues is unknown","Structural basis for competitive binding between CYTL1 and MDM2 on NDUFV1 N-terminus not resolved","Whether the glycolytic regulatory role requires NDUFV1's enzymatic activity or is purely scaffolding is unclear"]},{"year":2022,"claim":"Modeling compound heterozygous NDUFV1 variants at subunit interfaces in the bacterial homolog nuoF demonstrated that interface mutations reduce both NADH oxidase activity and complex assembly, establishing subunit contacts as critical for enzyme integrity.","evidence":"E. coli mutagenesis with membrane vesicle NADH oxidase assays, Co-IP, and time-delayed expression assays","pmids":["36462614"],"confidence":"Medium","gaps":["Bacterial system lacks eukaryotic assembly factors and supercomplexes","Quantitative correlation between assembly defect severity and patient phenotype not established"]},{"year":2023,"claim":"Gain- and loss-of-function experiments in renal ischemia-reperfusion injury demonstrated that NDUFV1 levels are rate-limiting for maintaining mitochondrial integrity, Complex I function, and cell survival under oxidative stress.","evidence":"In vivo mouse renal I/R model with NDUFV1 overexpression; siRNA knockdown in TCMK-1 cells with Complex I activity, mitochondrial morphology, and apoptosis assays","pmids":["37029501"],"confidence":"Medium","gaps":["Whether NDUFV1 overexpression benefits are mediated solely through Complex I activity or also through non-respiratory interactions (e.g., Src/LDHA axis) is unexplored","Long-term renal outcomes not assessed"]},{"year":null,"claim":"Key unresolved questions include the structural basis for how NDUFV1 integrates into mammalian supercomplexes, whether its Src-dependent glycolytic regulatory function operates in normal physiology beyond cancer, and the quantitative relationship between residual NDUFV1 activity and clinical severity across different tissue types.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of human NDUFV1 in the context of supercomplex assembly intermediates","Non-respiratory functions of NDUFV1 tested only in cancer cell lines","Genotype-phenotype correlations across tissues not systematically established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,3,6,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,3,7,8]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,3,6,8]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,8]}],"complexes":["Complex I (NADH:ubiquinone oxidoreductase)"],"partners":["CYTL1","MDM2","SRC","LDHA"],"other_free_text":[]},"mechanistic_narrative":"NDUFV1 encodes the 51-kDa flavoprotein subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), serving as the primary NADH oxidation site and electron entry point into the respiratory chain. The subunit binds the FMN cofactor required for NADH oxidation and coordinates iron–sulfur clusters essential for electron transfer; pathogenic missense mutations either abolish FMN binding, disrupt Complex I assembly at subunit interfaces, or impair catalytic activity, and complementation with wild-type NDUFV1 rescues protein level, assembly, and enzymatic function [PMID:26345448, PMID:33182419, PMID:36462614]. Beyond its canonical respiratory chain role, NDUFV1 protein stability is regulated by CYTL1-mediated competitive blockade of MDM2-dependent proteasomal degradation; stabilized NDUFV1 interacts with Src kinase to suppress LDHA-Y10 phosphorylation, thereby restraining aerobic glycolysis [PMID:35115484]. Biallelic loss-of-function mutations in NDUFV1 cause mitochondrial Complex I deficiency presenting as Leigh syndrome and leukoencephalopathy [PMID:33182419, PMID:21696386]."},"prefetch_data":{"uniprot":{"accession":"P49821","full_name":"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial","aliases":["Complex I-51kD","CI-51kD","NADH dehydrogenase flavoprotein 1","NADH-ubiquinone oxidoreductase 51 kDa subunit"],"length_aa":464,"mass_kda":50.8,"function":"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:28844695). Part of the peripheral arm of the enzyme, where the electrons from NADH are accepted by flavin mononucleotide (FMN) and then passed along a chain of iron-sulfur clusters by electron tunnelling to the final acceptor ubiquinone (PubMed:28844695). Contains FMN, which is the initial electron acceptor as well as one iron-sulfur cluster (PubMed:28844695)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/P49821/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDUFV1","classification":"Not Classified","n_dependent_lines":314,"n_total_lines":1208,"dependency_fraction":0.2599337748344371},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NDUFV1","total_profiled":1310},"omim":[{"mim_id":"620135","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 39; MC1DN39","url":"https://www.omim.org/entry/620135"},{"mim_id":"618226","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5","url":"https://www.omim.org/entry/618226"},{"mim_id":"618225","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4","url":"https://www.omim.org/entry/618225"},{"mim_id":"603846","title":"NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 3; NDUFS3","url":"https://www.omim.org/entry/603846"},{"mim_id":"603842","title":"NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B7; NDUFB7","url":"https://www.omim.org/entry/603842"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NDUFV1"},"hgnc":{"alias_symbol":["CI-51K"],"prev_symbol":[]},"alphafold":{"accession":"P49821","domains":[{"cath_id":"3.40.50.11540","chopping":"36-263","consensus_level":"high","plddt":97.3856,"start":36,"end":263},{"cath_id":"3.10.20.600","chopping":"272-357","consensus_level":"high","plddt":97.9424,"start":272,"end":357},{"cath_id":"1.20.1440.230","chopping":"363-462","consensus_level":"high","plddt":97.2492,"start":363,"end":462}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49821","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49821-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49821-F1-predicted_aligned_error_v6.png","plddt_mean":93.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDUFV1","jax_strain_url":"https://www.jax.org/strain/search?query=NDUFV1"},"sequence":{"accession":"P49821","fasta_url":"https://rest.uniprot.org/uniprotkb/P49821.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49821/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49821"}},"corpus_meta":[{"pmid":"11349233","id":"PMC_11349233","title":"Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11349233","citation_count":218,"is_preprint":false},{"pmid":"17786189","id":"PMC_17786189","title":"Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17786189","citation_count":68,"is_preprint":false},{"pmid":"23266820","id":"PMC_23266820","title":"Leigh syndrome associated with mitochondrial complex I deficiency due to novel mutations In NDUFV1 and NDUFS2.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23266820","citation_count":48,"is_preprint":false},{"pmid":"17162199","id":"PMC_17162199","title":"Early-onset ophthalmoplegia in Leigh-like syndrome due to NDUFV1 mutations.","date":"2007","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17162199","citation_count":47,"is_preprint":false},{"pmid":"26345448","id":"PMC_26345448","title":"Characterization of clinically identified mutations in NDUFV1, the flavin-binding subunit of respiratory complex I, using a yeast model system.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26345448","citation_count":44,"is_preprint":false},{"pmid":"8288251","id":"PMC_8288251","title":"Chromosomal localization of the human gene encoding the 51-kDa subunit of mitochondrial complex I (NDUFV1) to 11q13.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8288251","citation_count":31,"is_preprint":false},{"pmid":"25615419","id":"PMC_25615419","title":"Broad phenotypic variability in patients with complex I deficiency due to mutations in NDUFS1 and NDUFV1.","date":"2015","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/25615419","citation_count":30,"is_preprint":false},{"pmid":"18991197","id":"PMC_18991197","title":"MR spectroscopy and serial magnetic resonance imaging in a patient with mitochondrial cystic leukoencephalopathy due to complex I deficiency and NDUFV1 mutations and mild clinical course.","date":"2008","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/18991197","citation_count":30,"is_preprint":false},{"pmid":"21696386","id":"PMC_21696386","title":"A novel NDUFV1 gene mutation in complex I deficiency in consanguineous siblings with brainstem lesions and Leigh syndrome.","date":"2011","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21696386","citation_count":25,"is_preprint":false},{"pmid":"35115484","id":"PMC_35115484","title":"Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer.","date":"2022","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35115484","citation_count":24,"is_preprint":false},{"pmid":"9571201","id":"PMC_9571201","title":"Cloning of the human mitochondrial 51 kDa subunit (NDUFV1) reveals a 100% antisense homology of its 3'UTR with the 5'UTR of the gamma-interferon inducible protein (IP-30) precursor: is this a link between mitochondrial myopathy and inflammation?","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9571201","citation_count":21,"is_preprint":false},{"pmid":"23562761","id":"PMC_23562761","title":"A novel familial case of diffuse leukodystrophy related to NDUFV1 compound heterozygous mutations.","date":"2013","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/23562761","citation_count":18,"is_preprint":false},{"pmid":"30090137","id":"PMC_30090137","title":"Late-Onset Leigh Syndrome due to NDUFV1 Mutation in a 10-Year-Old Boy Initially Presenting with Ataxia.","date":"2018","source":"Journal of pediatric neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/30090137","citation_count":17,"is_preprint":false},{"pmid":"37029501","id":"PMC_37029501","title":"NDUFV1 attenuates renal ischemia-reperfusion injury by improving mitochondrial homeostasis.","date":"2023","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37029501","citation_count":16,"is_preprint":false},{"pmid":"29948731","id":"PMC_29948731","title":"Cystic Leucoencephalopathy in NDUFV1 Mutation.","date":"2018","source":"Indian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/29948731","citation_count":14,"is_preprint":false},{"pmid":"34807224","id":"PMC_34807224","title":"NDUFV1 mutations in complex I deficiency: Case reports and review of symptoms.","date":"2021","source":"Genetics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34807224","citation_count":13,"is_preprint":false},{"pmid":"33182419","id":"PMC_33182419","title":"Leigh Syndrome Due to NDUFV1 Mutations Initially Presenting as LBSL.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33182419","citation_count":13,"is_preprint":false},{"pmid":"29395179","id":"PMC_29395179","title":"A Heterozygous NDUFV1 Variant Aggravates Mitochondrial Complex I Deficiency in a Family with a Homoplasmic ND1 Variant.","date":"2018","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/29395179","citation_count":13,"is_preprint":false},{"pmid":"32871395","id":"PMC_32871395","title":"Induced pluripotent stem cell line UOMi002-A from a patient with Leigh syndrome with compound heterozygous mutations in the NDUFV1 gene.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32871395","citation_count":12,"is_preprint":false},{"pmid":"35482246","id":"PMC_35482246","title":"Compound heterozygous mutations of NDUFV1 identified in a child with mitochondrial complex I deficiency.","date":"2022","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/35482246","citation_count":9,"is_preprint":false},{"pmid":"36163075","id":"PMC_36163075","title":"The neuropathologic findings in a case of progressive cavitating leukoencephalopathy due to NDUFV1 pathogenic variants.","date":"2022","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/36163075","citation_count":9,"is_preprint":false},{"pmid":"36896486","id":"PMC_36896486","title":"A cryptic pathogenic NDUFV1 variant identified by RNA-seq in a patient with normal complex I activity in muscle and transient magnetic resonance imaging changes.","date":"2023","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/36896486","citation_count":7,"is_preprint":false},{"pmid":"38626668","id":"PMC_38626668","title":"NDUFV1-Related Mitochondrial Complex-1 Disorders: A Retrospective Case Series and Literature Review.","date":"2024","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38626668","citation_count":6,"is_preprint":false},{"pmid":"9892733","id":"PMC_9892733","title":"The structure of the human NDUFV1 gene encoding the 51-kDa subunit of mitochondrial complex I.","date":"1999","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/9892733","citation_count":6,"is_preprint":false},{"pmid":"34936716","id":"PMC_34936716","title":"Overexpression of NDUFV1 alleviates renal damage by improving mitochondrial function in unilateral ureteral obstruction model mice.","date":"2022","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/34936716","citation_count":4,"is_preprint":false},{"pmid":"35482023","id":"PMC_35482023","title":"Early-onset leukoencephalomyelopathy due to a biallelic NDUFV1 variant in a mid-forties patient.","date":"2022","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35482023","citation_count":4,"is_preprint":false},{"pmid":"36462614","id":"PMC_36462614","title":"Analysis of compound heterozygous and homozygous mutations found in peripheral subunits of human respiratory Complex I, NDUFS1, NDUFS2, NDUFS8 and NDUFV1, by modeling in the E. coli enzyme.","date":"2022","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/36462614","citation_count":2,"is_preprint":false},{"pmid":"39525154","id":"PMC_39525154","title":"Leigh Syndrome Caused by Compound Heterozygous Variants c.1162A_C and c.1138G_C in the NDUFV1 Gene: A Case Report.","date":"2024","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/39525154","citation_count":1,"is_preprint":false},{"pmid":"40207266","id":"PMC_40207266","title":"Mitochondrial complex I deficiency in a 4-year-old boy due to compound heterozygous NDUFV1 mutation: a case report of a new pathogenic variant.","date":"2025","source":"Oxford medical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/40207266","citation_count":1,"is_preprint":false},{"pmid":"41140551","id":"PMC_41140551","title":"Progressive spinal cord involvement in Leigh syndrome due to an NDUFV1 variant.","date":"2025","source":"Radiology case reports","url":"https://pubmed.ncbi.nlm.nih.gov/41140551","citation_count":0,"is_preprint":false},{"pmid":"34134969","id":"PMC_34134969","title":"[A novel frameshift NDUFV1 mutation in a child with the phenotype of optic nerve atrophy].","date":"2021","source":"Nan fang yi ke da xue xue bao = Journal of Southern Medical University","url":"https://pubmed.ncbi.nlm.nih.gov/34134969","citation_count":0,"is_preprint":false},{"pmid":"40919011","id":"PMC_40919011","title":"Acute profound lactic alkalosis associated with NDUFV1 compound heterozygosity in a previously healthy 6-year-old female.","date":"2025","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/40919011","citation_count":0,"is_preprint":false},{"pmid":"42040813","id":"PMC_42040813","title":"Expression Study of NDUFS1, NDUFV1, and NDUFV2 in Schizophrenia and Paranoid Personality Disorder : Role of Mitochondrial Complex I in SCZ and PPD.","date":"2022","source":"Galen medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/42040813","citation_count":0,"is_preprint":false},{"pmid":"40681182","id":"PMC_40681182","title":"NDUFV1 mutation presenting as isolated progressive optic neuropathy: a unique manifestation of mitochondrial complex I deficiency.","date":"2025","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/40681182","citation_count":0,"is_preprint":false},{"pmid":"41952138","id":"PMC_41952138","title":"Novel NDUFV1 variant in progressive cavitating leukodystrophy with microcephaly: a case report.","date":"2026","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/41952138","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16038,"output_tokens":2399,"usd":0.042049},"stage2":{"model":"claude-opus-4-6","input_tokens":5689,"output_tokens":2522,"usd":0.137242},"total_usd":0.179291,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"NDUFV1 encodes the 51-kDa flavoprotein subunit of mitochondrial NADH:ubiquinone oxidoreductase (Complex I), playing an important role in formation of the NADH-binding site and serving as the principal site of electron entry from NADH into the respiratory chain. The gene was chromosomally localized to 11q13.\",\n      \"method\": \"PCR-based chromosomal localization (fluorescence in situ hybridization and somatic cell hybrid analysis); sequence analysis revealing NADH, FMN, and iron-sulfur binding site motifs\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational biochemical characterization of the subunit's role replicated across species; consensus across multiple studies\",\n      \"pmids\": [\"8288251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The NDUFV1 gene contains consensus motifs for NADH, FMN, and iron-sulfur binding within its coding sequence. Its 10-exon genomic structure was characterized, with a CpG island at the transcriptional start site (consistent with housekeeping function) and an NRF-2 binding site in the 5' flanking region. An unexpected 48-bp antisense homology between the NDUFV1 3'UTR and the 5'UTR of gamma-interferon inducible protein (IP-30) was identified.\",\n      \"method\": \"Genomic cloning, cDNA sequencing, Northern blotting, sequence motif analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — structural/sequence characterization with functional inference, single study\",\n      \"pmids\": [\"9571201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Transcription factor Sp1 directly activates NDUFV1 transcription; inhibition of Sp1/DNA binding by mithramycin reduced NDUFV1 mRNA levels in neuroblastoma cells, demonstrating Sp1 as a transcriptional regulator of NDUFV1.\",\n      \"method\": \"Pharmacological inhibition of Sp1 with mithramycin, promoter-binding assays, mRNA quantification in neuroblastoma cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional inhibitor assay in cells showing transcriptional control, single study\",\n      \"pmids\": [\"17786189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NDUFV1 binds the flavin (FMN) cofactor that oxidizes NADH and is the site of Complex I-mediated reactive oxygen species (ROS) production. Sixteen pathogenic missense mutations were functionally characterized: some caused loss of complex I expression, two resulted in assembled but flavin-free complex I, and four produced functionally compromised enzymes; three variants yielded wild-type-equivalent function, challenging their pathogenic assignment.\",\n      \"method\": \"Yarrowia lipolytica yeast model system; complex I assembly assays, flavin content measurement, NADH oxidation activity assays, mutagenesis of all 16 variants\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted yeast model with enzymatic assays and mutagenesis of multiple variants, strong mechanistic resolution\",\n      \"pmids\": [\"26345448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Arg386 in NDUFV1 is critical for coordinating iron-sulfur clusters; the p.Arg386His mutation affects a conserved residue contiguous to a cysteine that coordinates an Fe ion in the 4Fe-4S domain, validating the molecular model of iron-sulfur cluster coordination by NDUFV1.\",\n      \"method\": \"Homozygosity mapping, Sanger sequencing, protein conservation analysis, structural modeling\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic and structural modeling evidence; functional inference supported by structural proximity to iron-sulfur coordinating cysteine\",\n      \"pmids\": [\"21696386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CYTL1 protein competitively binds the N-terminal sequence of NDUFV1 to block MDM2-mediated proteasomal degradation of NDUFV1, thereby stabilizing NDUFV1 protein levels. Stabilized NDUFV1 in turn interacts with Src kinase to attenuate LDHA phosphorylation at tyrosine 10, reducing lactate production and inhibiting glycolytic reprogramming in breast cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, pulldown assays, proteasome inhibitor experiments, NDUFV1 overexpression/knockdown, metabolic assays (glucose uptake, lactate production), in vitro and in vivo tumor models\",\n      \"journal\": \"Signal transduction and targeted therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP for protein-protein interactions, functional rescue experiments, and defined metabolic phenotype with multiple orthogonal methods in a single study\",\n      \"pmids\": [\"35115484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Pathogenic mutations in NDUFV1 mapped to subunit interfaces disrupt Complex I assembly; compound heterozygous variants in NDUFV1 (modeled in the homologous E. coli nuoF subunit) showed reduced NADH oxidase activity and impaired complex assembly as measured by co-immunoprecipitation and time-delayed expression assays.\",\n      \"method\": \"E. coli model system mutagenesis, membrane vesicle NADH oxidase activity assays, co-immunoprecipitation assembly assays, time-delayed expression assays\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/2 — bacterial reconstitution with functional assays and assembly assays, single study but multiple orthogonal methods\",\n      \"pmids\": [\"36462614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NDUFV1 overexpression in renal tubular cells improves mitochondrial integrity and Complex I activity, reduces oxidative stress and apoptosis following ischemia-reperfusion injury; NDUFV1 knockdown aggravated H2O2-induced cell injury, establishing NDUFV1 as required for maintaining mitochondrial homeostasis and Complex I function.\",\n      \"method\": \"In vivo mouse renal I/R model with NDUFV1 overexpression, siRNA knockdown in TCMK-1 cells, Complex I activity assays, mitochondrial morphology assessment, oxidative stress and apoptosis assays\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss- and gain-of-function in both in vivo and in vitro models with defined cellular phenotypes, single study\",\n      \"pmids\": [\"37029501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Biallelic loss-of-function mutations in NDUFV1 cause loss of NDUFV1 protein, defective Complex I assembly, and reduced Complex I enzyme activity; complementation with wild-type NDUFV1 restored NDUFV1 protein level, Complex I assembly, and enzyme activity, directly demonstrating the requirement of NDUFV1 for Complex I assembly and function.\",\n      \"method\": \"Patient-derived cell lines, Western blot for NDUFV1 protein, blue-native PAGE for Complex I assembly, spectrophotometric Complex I enzyme assay, complementation assay with NDUFV1 re-expression\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — complementation rescue with multiple orthogonal readouts (protein, assembly, enzymatic activity) in patient-derived cells\",\n      \"pmids\": [\"33182419\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDUFV1 is the 51-kDa flavin (FMN)-binding core subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase) that constitutes the primary NADH oxidation site and the main entry point for electrons into the respiratory chain, harbors iron-sulfur cluster coordination residues (including a critical Arg386 adjacent to a 4Fe-4S coordinating cysteine), and is the site of Complex I-mediated ROS production; its protein stability is regulated by CYTL1-mediated protection from MDM2-dependent proteasomal degradation, and once stabilized, NDUFV1 interacts with Src to suppress LDHA-Y10 phosphorylation and limit glycolysis, while pathogenic mutations disrupt FMN binding or Complex I assembly, leading to mitochondrial respiratory chain deficiency and diseases including Leigh syndrome and leukoencephalopathy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NDUFV1 encodes the 51-kDa flavoprotein subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), serving as the primary NADH oxidation site and electron entry point into the respiratory chain. The subunit binds the FMN cofactor required for NADH oxidation and coordinates iron–sulfur clusters essential for electron transfer; pathogenic missense mutations either abolish FMN binding, disrupt Complex I assembly at subunit interfaces, or impair catalytic activity, and complementation with wild-type NDUFV1 rescues protein level, assembly, and enzymatic function [PMID:26345448, PMID:33182419, PMID:36462614]. Beyond its canonical respiratory chain role, NDUFV1 protein stability is regulated by CYTL1-mediated competitive blockade of MDM2-dependent proteasomal degradation; stabilized NDUFV1 interacts with Src kinase to suppress LDHA-Y10 phosphorylation, thereby restraining aerobic glycolysis [PMID:35115484]. Biallelic loss-of-function mutations in NDUFV1 cause mitochondrial Complex I deficiency presenting as Leigh syndrome and leukoencephalopathy [PMID:33182419, PMID:21696386].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of NDUFV1 as the gene encoding the 51-kDa flavoprotein of Complex I established the molecular identity of the principal NADH oxidation site and electron entry point of the mitochondrial respiratory chain.\",\n      \"evidence\": \"PCR-based chromosomal localization, FISH, and sequence motif analysis revealing NADH, FMN, and Fe-S binding sites\",\n      \"pmids\": [\"8288251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No direct enzymatic reconstitution performed at this stage\",\n        \"Functional consequence of individual binding motifs not tested by mutagenesis\"\n      ]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Characterization of the 10-exon genomic structure, CpG island promoter, and NRF-2 binding site established NDUFV1 as a housekeeping gene under transcriptional control relevant to mitochondrial biogenesis.\",\n      \"evidence\": \"Genomic cloning, cDNA sequencing, Northern blotting, and promoter motif analysis\",\n      \"pmids\": [\"9571201\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"NRF-2-dependent transcriptional regulation not tested functionally\",\n        \"Biological significance of the antisense homology to IP-30 3′UTR unknown\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstration that Sp1 directly activates NDUFV1 transcription identified a specific transcription factor pathway controlling expression of this core respiratory chain subunit.\",\n      \"evidence\": \"Mithramycin-mediated Sp1 inhibition with mRNA quantification in neuroblastoma cells\",\n      \"pmids\": [\"17786189\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct Sp1 binding to the NDUFV1 promoter not confirmed by ChIP\",\n        \"Relative contributions of Sp1 versus NRF-2 to physiological NDUFV1 expression unresolved\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The p.Arg386His mutation established that Arg386 is critical for iron–sulfur cluster coordination in the 4Fe-4S domain of NDUFV1, linking structural integrity of the Fe-S center to disease pathogenesis.\",\n      \"evidence\": \"Homozygosity mapping, Sanger sequencing, conservation analysis, and structural modeling in patients with Complex I deficiency\",\n      \"pmids\": [\"21696386\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct biochemical measurement of Fe-S cluster content or redox activity for this mutant\",\n        \"Functional impact inferred from structural proximity rather than reconstituted enzyme assays\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Systematic mutagenesis of 16 pathogenic NDUFV1 variants resolved how individual mutations cause disease—either by preventing FMN incorporation, abolishing Complex I assembly, or producing catalytically impaired enzyme—and reclassified three variants as non-pathogenic.\",\n      \"evidence\": \"Yarrowia lipolytica reconstitution with assembly assays, flavin content measurement, and NADH oxidation activity for each variant\",\n      \"pmids\": [\"26345448\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"ROS production rates of individual mutant enzymes not quantified\",\n        \"Findings in yeast model await confirmation in mammalian Complex I context\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Complementation rescue in patient-derived cells provided direct proof that NDUFV1 is required for Complex I assembly and enzymatic activity, closing the gap between genetic association and biochemical causality.\",\n      \"evidence\": \"Patient-derived cell lines with biallelic mutations; Western blot, BN-PAGE, spectrophotometric Complex I assay, and rescue by wild-type NDUFV1 re-expression\",\n      \"pmids\": [\"33182419\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Tissue-specific consequences (e.g., in neurons) not modeled\",\n        \"Supercomplex formation status in rescued cells not assessed\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery that CYTL1 stabilizes NDUFV1 by blocking MDM2-mediated proteasomal degradation, and that stabilized NDUFV1 interacts with Src to suppress LDHA-Y10 phosphorylation, revealed an unexpected non-respiratory function of NDUFV1 in restraining glycolytic reprogramming.\",\n      \"evidence\": \"Reciprocal Co-IP, proteasome inhibitor experiments, metabolic assays, and in vivo tumor models in breast cancer cells\",\n      \"pmids\": [\"35115484\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the NDUFV1-Src interaction occurs in non-cancer tissues is unknown\",\n        \"Structural basis for competitive binding between CYTL1 and MDM2 on NDUFV1 N-terminus not resolved\",\n        \"Whether the glycolytic regulatory role requires NDUFV1's enzymatic activity or is purely scaffolding is unclear\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Modeling compound heterozygous NDUFV1 variants at subunit interfaces in the bacterial homolog nuoF demonstrated that interface mutations reduce both NADH oxidase activity and complex assembly, establishing subunit contacts as critical for enzyme integrity.\",\n      \"evidence\": \"E. coli mutagenesis with membrane vesicle NADH oxidase assays, Co-IP, and time-delayed expression assays\",\n      \"pmids\": [\"36462614\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Bacterial system lacks eukaryotic assembly factors and supercomplexes\",\n        \"Quantitative correlation between assembly defect severity and patient phenotype not established\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Gain- and loss-of-function experiments in renal ischemia-reperfusion injury demonstrated that NDUFV1 levels are rate-limiting for maintaining mitochondrial integrity, Complex I function, and cell survival under oxidative stress.\",\n      \"evidence\": \"In vivo mouse renal I/R model with NDUFV1 overexpression; siRNA knockdown in TCMK-1 cells with Complex I activity, mitochondrial morphology, and apoptosis assays\",\n      \"pmids\": [\"37029501\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether NDUFV1 overexpression benefits are mediated solely through Complex I activity or also through non-respiratory interactions (e.g., Src/LDHA axis) is unexplored\",\n        \"Long-term renal outcomes not assessed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for how NDUFV1 integrates into mammalian supercomplexes, whether its Src-dependent glycolytic regulatory function operates in normal physiology beyond cancer, and the quantitative relationship between residual NDUFV1 activity and clinical severity across different tissue types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of human NDUFV1 in the context of supercomplex assembly intermediates\",\n        \"Non-respiratory functions of NDUFV1 tested only in cancer cell lines\",\n        \"Genotype-phenotype correlations across tissues not systematically established\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 3, 6, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 3, 7, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 3, 6, 8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 8]}\n    ],\n    \"complexes\": [\n      \"Complex I (NADH:ubiquinone oxidoreductase)\"\n    ],\n    \"partners\": [\n      \"CYTL1\",\n      \"MDM2\",\n      \"SRC\",\n      \"LDHA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}